New cell-probing technology for early breast cancer surgery
Part of Cancer, Skin clinical trials.
This trial tests a new technology that helps doctors examine cells during surgery for early-stage breast cancer. It may help make the sentinel lymph node biopsy more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are female.
- You have been diagnosed with invasive breast cancer or ductal carcinoma in situ (an early form of breast cancer).
- Your doctor plans to do a sentinel lymph node biopsy (a procedure to check if cancer has spread to the first lymph nodes).
- You are willing to take part in the study and sign a consent form.
- You do not have an allergy to methylene blue or sodium citrate (dyes used in the procedure).
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method using tiny particles that glow when they find cancer cells on the edges of removed breast tissue and in lymph nodes. The goal is to help surgeons see if any cancer is left behind during the same surgery, so they can remove it right away.
This trial uses a special probe that lights up cancer cells to quickly check if breast cancer has spread to nearby lymph nodes. It may help doctors decide how much surgery is needed.
This trial tests a “sentinel node” biopsy, using a special dye/tracer, during surgery for early-stage endometrial cancer. It may help doctors find whether cancer has spread to lymph nodes while possibly avoiding more extensive lymph node removal.
This trial tests a new method to find and remove lymph nodes in the armpit after chemotherapy shrinks breast cancer. It uses a safe blue dye to help surgeons identify which nodes to remove, potentially reducing complications while ensuring thorough treatment.
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
This study tests a scanner (Histolog®) that checks the edges of removed breast tissue during surgery to make sure all cancer is removed. The goal is to reduce the need for a second surgery.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.